Genmab A/S

446 articles about Genmab A/S

• Genmab A/S Announces 2007 First Quarter Results

  5/8/2007

• Biolex Therapeutics Announces Agreement With Genmab, Inc. for New Class of Antibodies

  5/7/2007

• Genmab A/S Initiates HuMax-EGFr Combination Study in Non Small Cell Lung Cancer

  4/12/2007

• New Insights Into Novel Mechanisms of Action of Genmab A/S's HuMax-EGFr

  3/12/2007

• Medarex, Inc. Announces Sale Of Shares In Genmab A/S

  2/20/2007

• Genmab A/S Announces Year End 2006 Financial Results

  2/13/2007

• Genmab A/S Release: Global Agreement For HuMax-CD20 Receives Antitrust Clearance

  2/6/2007

• Genmab A/S Financial Calendar For 2007

  1/2/2007

• The Day In Review: GlaxoSmithKline Pays Record For Genmab A/S Cancer Drug

  12/18/2006

• Genmab A/S Announces HuMax-ZP3 Cancer Program

  12/13/2006

• Genmab A/S Initiates HuMax-CD20 Front Line CLL Study

  12/11/2006

• Genmab A/S Announces Additional Positive Results In HuMax-CD20 CLL Phase I/II Study

  12/11/2006

• Genmab A/S Announces Positive Interim Data For The HuMax-CD20 Phase II RA Study

  12/5/2006

• Genmab A/S Licenses MIF Receptor Target From Cytokine PharmaSciences

  11/20/2006

• Genmab A/S Announces Results For The First Nine Months Of 2006

  10/31/2006

• Genmab A/S Initiates Combination Study Of HuMax-EGFr With Chemo-Radiation

  10/24/2006

• Genmab A/S Hosts Research, Development And Business Update

  10/18/2006

• Genmab A/S Completes Accrual In HuMax-CD20 Phase II RA Study

  9/22/2006

• Genmab A/S Initiates HuMax-EGFr Pivotal Study In Refractory Head And Neck Cancer

  9/14/2006

• Genmab A/S Initiates Ofatumumab (Humax-Cd20) Pivotal Study In NHL

  7/10/2006